Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in Gulf Cooperation Council Countries
Clinical trial NCT05315323 · COMPLETED
Trial details
- NCT number
- NCT05315323
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-23
- Primary completion
- 2024-06-27
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.